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Abstract: COPHELA (Cooperation in Quality Assurance for Pharmacy Education and Training
between Europe and Latin America), a collaborative project between the European Union (EU) and
Latin America, will produce on-line courses for the master degree in pharmacy. The program runs
from 2019 through 2021. It is funded by the Erasmus+ program of the Education, Audio-visual
and Culture Executive Agency (EACEA) of the European Commission. The partners are EU and
Latin American universities. These are accompanied by associated partners from EU and Latin
American universities, as well as from governmental and non-governmental organizations, such as
pharmacy chambers and educational associations. The project is coordinated by the University of
Granada, Spain (first author of this paper). It will produce distance learning master degree courses in
a dozen fields of specialized pharmaceutical science education and practice, ranging from patient
care to industrial pharmacy. This paper describes the design of the project and is intended to evoke
constructive comments. It also represents a call for the recruitment of additional associated partners.
Keywords: pharmacy; education; specialization; master degree; distance learning; European Union;
Latin America; cooperation; patient safety; pharmaceutical industry
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1. Introduction
In light of the evolving situation in pharmacy specialization in Latin America, the COPHELA
project proposes to produce distant learning tools for master degrees in pharmacy specialization.
These will be published in Spanish, Portuguese and/or English, and will be available primarily for the
Latin American market but also in the EU.
This COPHELA project is a follow-on to three previous EU-funded projects:
1. PHARMINE (Pharmacy Education in Europe) [1,2], and the derivatives of PHARMINE viz
2. PHAR-QA (Quality Assurance in European Pharmacy Education and Training) [3,4], and
3. PHAR-IN (Competences for industrial pharmacy practice in biotechnology) [5,6].
All three projects centered on:
1. The competences for fundamental and specialized pharmacy practice (community,
hospital and industry)
2. The education and training tools necessary to produce the competences cited previously in
(1) above, and
3. The harmonization of competences, and the education and training tools necessary, in the EU
member states.
The purpose of the three previous projects was to adapt pharmacy education in the EU to
the on-going evolution in practice. For example, community and hospital pharmacies are moving
towards patient care activities, such as therapeutic monitoring, intervention in public health campaigns
(vaccination and other), medicinal treatment of long-term ailments, and interpretation of clinical
biological results, etc. There is also a substantial transformation in industrial pharmacy in research
and development, production, etc. This accompanies the shift in therapeutics from small chemical
drug molecules to large protein biosimilars. The development of the generic drug market with the
consequential changes in marketing, regulatory affairs, etc., is another example of the evolution
in practice.
COPHELA looks at the paradigms and technology required to extend to Latin America the
principles behind the three EU PHARMINE projects. It aims at creating master degree courses in
specialized pharmaceutical sciences to meet the challenges of the changing face of pharmacy. Below,
we examine the characteristics of pharmacy practice in the EU and Latin America, and how specialized
education and training can provide possibilities for adaptation in the changing world.
1.1. Characteristics of Pharmacy Practice
The attributes of pharmacy practice, with examples from the EU and Latin America, are:
1. Workplace. A hospital pharmacist can be defined as a pharmacist working in a hospital pharmacy
-and this independently of the education and training s/he has followed. An industrial pharmacist
can be defined as a pharmacist working for a drug company. In both cases –hospital and industrial
– this attribute is independent of the following three attributes.
2. Specific pharmaceutical activities. This concerns the definitions of the practice of community
and hospital pharmacy (and to a lesser extent industrial pharmacy). Such definitions involve
pharmaceutical acts like formulation of specific forms of drugs or deliverance of specific drug
treatments. The practitioners’ perceptions of such acts have been described in detail [7–9].
3. Laws and directives. The definition of attribute 2 –pharmacy practice –is established through
laws and directives from national associations and/or chambers, and, in the case of the EU,
by directives drafted by the European Commission and approved by the European Parliament.
It should be noted that a directive is an act that requires a given country to achieve a result without
dictating the means of achieving that result. Thus hospital pharmacy in Spain and Portugal are
governed by associations and chambers [10,11], and identified as specific activities by national
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law [12,13]. At the pan-European level, an EU directive [14] defines pharmacy practice (and
education), setting out rulings on subject matters such as patient care, this EU directive does not
mention hospital pharmacies as such. With respect to industrial pharmacy practice and education,
the EU directive again does not acknowledge the existence of industrial pharmacy specialization,
but does specify that subjects, such as “manufacture and testing of medicinal products” are part
of the “professional experience” of the pharmacist. At a national level, in Spain and Portugal,
industrial pharmacy is taught as a master’s degree [15–18], and industrial pharmacists are
represented by specific chambers or associations [19,20]. The study of legislation on pharmacy
specialization in Latin America is the first objective of COPHELA.
4. Education and training. This attribute concerns the education and training for fundamental
practice and for specialized practice in hospital and industrial pharmacy. As an example, in Spain
and Portugal, hospital pharmacy practice is taught in specific hospital pharmacy specialization
courses [21,22]. Concerning Latin America, the second objective of COPHELA is to create and
install education and training for specialized pharmacy practice. It is interesting to note that
the recognition of specialization in pharmacy involves the creation of master degree courses,
thus evolution in education goes hand in hand with evolution in pharmacy practice [23].
1.2. The COPHELA Project
Below, are the paradigms and methodology to achieve these aims.
2. Methodology
The first stage in the elaboration of the COPHELA project was to constitute a core team of
10 partners (authors of this paper) who replied to the following criteria:
• Evidence of collaboration between the EU and Latin America in the form of student and/or staff
exchange, joint projects in education and training and/or research, etc.
• Present and future development of specialization in pharmacy practice in the fields of patient
care, research in pharmaceutical science and/or education, etc.
• Development of IT capacity in teaching.
• Interaction with national and international governmental departments (education, health . . . ),
pharmacy chambers and associations, etc.
EACEA/EU projects are separated into “workpackages” (WPs) that group the activities of the
project. WPs function independently but rely on the results of other WPs. Figure 1 shows the
organization of the WPs. WP “management” coordinates the project, whereas WP “quality plan”
audits the project. These two WPs operate throughout the project. WP “preparation” sets the stage
for the project; WP “development” produces the on-line courses. WP “dissemination” ensures that
the courses developed are available to all those concerned, and WP “exploitation” guarantees that
the on-line courses are used by all potential partners during, and after, the lifetime of the project.
The chronological order of the WPs “preparation” through “exploitation” is shown by the arrow at the
bottom of the figure.
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Figure 1. Structure of the COPHELA project. EAFP: European Association of Faculties of Pharmacy [24]; COIFFA: Conferencia Iberoamericana de Facultades de 
Farmacia [25].
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Figu e 1. Struc ure of the COPHELA project. AFP: European Association of Faculties of Pharmacy [24]; COIFFA: Conferenci Iberoamericana de Facultades de
Farmacia [25].
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3. Discussion
The target group and the ultimate beneficiaries of the COPHELA project are the populations of
the Latin American countries. Benefit will come in various forms. Firstly, there will be an improvement
in the healthcare of the Latin American population, following the amelioration of pharmaceutical
care, based on the upgrade of pharmaceutical specialization in community and hospital pharmacies.
Secondly, the Latin American pharmaceutical industry will benefit by providing employees with the
tools required for future changes in the industry, such as the change from a chemistry-based industry
producing small molecules to a biotechnology-based industry producing large therapeutic proteins.
There are several potential issues. Firstly, they involve shortcomings in the performance of the
partners and their capacity to produce, evaluate and accredit satisfactory courses. in the time given.
Appropriate expedient measures to counter such deficiencies are based on the capacity of the auditing
to detect and suggest solutions, and a satisfactory interaction with EACEA and project partners.
Secondly, problems could arise in the accreditation of courses by bodies external to the project
such as government health and education authorities, and thus, in the long-term use of COPHELA
material post-2021, the official date of the closure of the project. The main purpose of COPHELA
accreditation is recognition. The project in its present form has 44 partners and associated partners in
the EU and Latin America. The fact that all the COPHELA universities and other institutions have
contacts with the accreditation authorities in their different countries should ensure that such problems
can be resolved.
Thirdly, in parallel to accreditation, problems could arise concerning intellectual property and
ownership of the material produced given that in the EU and in Latin America the economics of the
education and training of pharmacists vary greatly. This ranges from the situation in state-owned
universities where such education and training are without charge, to that in private universities with
a fee system. Here, solutions will be found on the basis of interactions between the project partners
and associated partners, and the relevant partners in the healthcare system of the country concerned.
Ownership will be guaranteed by the commitments and conventions on a joint project. Intellectual
property rights will be ensured through Creative Commons Licenses [26].
4. Conclusions
COPHELA is a collaborative project between the EU and Latin America aimed at improving
specialization education in pharmacy. Its ambition is to improve not only the competences of target
groups, such as university staff and students, and pharmaceutical professionals, but also the wellbeing
and prosperity of the general public through better patient care, and better drugs, with a modernized
pharmaceutical industry capable of providing the latter. The purpose of this manuscript is to request
comments on project design and recruit potential research partners.
Author Contributions: The paper was written by J.A.; the other authors: A.S.-P., A.M.C., P.B., M.O.R., C.T.Q.-B.,
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Appendix A
Associated partners/Universities:
Spain:
Universidad de Alcalá, Faculty of Pharmacy – UAH, Alcala de Henares, Madrid, Spain. http:
//www.uah.es/;
Universidad de Salamanca, Faculty of Pharmacy – USAL, Salamanca, Spain. http://www.usal.es/
webusal/en/node/24;
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Universidad Complutense de Madrid, Facultad de Farmacia – UCM, Madrid, Spain. http:
//www.ucm.es/;
Universidad de Santiago de Compostela, Facultad de Farmacia – USC, Santiago de Compostela,
Spain. http://www.usc.es/;
Universidad de Valencia, Facultad de Farmacia – UV, Valencia, Spain. http://www.uv.es/;
Portugal:
Universidade de Coimbra Facultade de Farmacia, Coimbra, Portugal – UC. http://www.uc.pt/;
Italy:
Università degli Studi di Perugia – UNIPG, Perugia, Italy. http://www.unipg.it/en/;
Università degli Studi Guglielmo Marconi – UNIMARCONI, Rome, Italy. www.unimarconi.it;
Brazil:
Universidade de São Paulo, Faculty of Pharmaceutical Sciences – USP, Sao Paulo, Brazil. http:
//www5.usp.br/;
Argentina:
Universidad Nacional de Córdoba, Department of Pharmacy of the Chemical Science Faculty –
UNC, Cordoba, Argentina. http://www.unc.edu.ar/;
Universidad Nacional de San Luis, Facultad de Quimica, Bioquimica y Farmacia – UNSL, San
Luis Argentina. http://www.unsl.edu.ar/;
Peru:
Universidad Antonio Guillermo Urrelo – UPAGU, Cajamarca, Peru. http://upagu.edu.pe/es/;
Universidad Norbert Wiener – UWIENER, Lima, Peru. http://www.uwiener.edu.pe/;
Costa Rica:
Universidad de Costa Rica – UCR, San José, Costa Rica. http://www.ucr.ac.cr/;
El Salvador:
Universidad José Matías Delgado – UJMD, San Salvador, El Salvador. http://www.ujmd.edu.sv/;
Ecuador:
Universidad Nacional de Chimborazo/Escuela Superior Politecnica del Chimborazo – ESPOCH,
Riobamba, Ecuador. http://www.espoch.edu.ec/;
Paraguay:
Universidad Nacional de Asunción – UNA, Asuncion, Paraguay. https://www.una.py/;
Venezuela:
Universidad de Los Andes – ULA, Merida, Venezuela. http://www.ula.ve/;
Associations and chambers.
Europe:
Real Academia Nacional de Farmacia – RANF, Madrid, Spain. http://www.ranf.com/;
Consejo General de Colegios Oficiales de Farmacéuticos de España – REDFARMA,
Madrid, Spain. http://www.portalfarma.com/profesionales/organizacionfcolegial/Paginas/
organizacionfarmaceuticacolegial.aspx;
Academia de Farmacia de Castilla y León, Salamanca, Spain. http://www.
academiadefarmaciacastillayleon.es/;
Academia Iberoamericana de Farmacia – NSACAN, Grenada/Seville, Spain. http://www.insacan.
org/aif/aif.html;
Asociación Universitaria Iberoamericana de Postgrado – AUIP, Salamanca, Spain. http://www.
auip.org/;
Sociedad Española de Farmacia Hospitalaria – SEFIG, Madrid, Spain. http://www.sefh.es/;
Istituto Italo-Latino Americano, Rome, Italy. http://www.esteri.it/mae/en/politica_estera/aree_
geografiche/americhe/istitutoitalolatinoamericano;
European Association of Hospital Pharmacy – EAHP, Brussels, Belgium. http://www.eahp.eu/;
European Association of Faculties of Pharmacy – EAFP, Msida, Malta. http://eafponline.eu/;
European Pharmacy Students Association – EPSA, Brussels, Belgium. http://www.epsa-online.org/;
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Latin America:
Academia de Ciências Farmacêuticas do Brasil – ACADEMIAFARMACIA, Rio de Janiero, Brazil.
http://www.academiafarmacia.org.br/;
Asociación de Quimicos Farmaceuticos del Paraguay, Asuncion, Paraguay.
Conferencia Iberoamericana de Facultades de Farmacia – COIFFA, Mexico City, Mexico. http:
//www.coiffa.org.mx/;
Unión de Universidades de América Latina y el Caribe – UDUAL, Mexico D.F., Mexico. www.
udual.org;
Erasmus Mundus Association Latin America Chapter – EMA, Mexico D.F., Mexico. http:
//www.em-a.eu/en/about-ema/regional-chapters/latin-american-chapter.html.
References
1. The PHARMINE (Pharmacy Education in Europe) Country Profile, Spain. 2011. Available online: https:
//www.pharmine.org/country-profiles/spain/ (accessed on 30 January 2020).
2. Atkinson, J.; Rombaut, B. The PHARMINE study on the impact of the European Union directive on sectoral
professions and of the Bologna declaration on pharmacy education in Europe. Pharm. Pract. 2011, 9, 4–20.
[CrossRef] [PubMed]
3. The PHAR-QA (Quality Assurance in European Pharmacy Education and Training) Project. Available online:
https://www.phar-qa.eu/ (accessed on 30 January 2020).
4. Atkinson, J. The Production of the PHAR-QA Competence Framework. Pharmacy 2017, 5, 19. [CrossRef]
[PubMed]
5. The PHAR-IN (Competences for Industrial Pharmacy Practice in Biotechnology) Project. Available online:
https://www.phar-in.eu/ (accessed on 30 January 2020).
6. Atkinson, J.; Crowley, P.; De Paepe, K.; Gennery, B.; Koster, A.; Martini, L.G.; Moffat, V.; Nicholson, J.;
Pauwels, G.; Ronsisvalle, G.; et al. A European Competence Framework for Industrial Pharmacy Practice in
Biotechnology. Pharmacy 2015, 3, 101–128. [CrossRef] [PubMed]
7. Atkinson, J.; De Paepe, K.; Pozo, A.S.; Rekkas, D.M.; Volmer, D.; Hirvonen, J.T.; Božicˇ, B.; Skowron, A.;
Mircioiu, C.; Marcincal, A.; et al. What is a Pharmacist: Opinions of Pharmacy Department Academics and
Community Pharmacists on Competences Required for Pharmacy Practice. Pharmacy 2016, 4, 12. [CrossRef]
[PubMed]
8. Atkinson, J.; Sánchez-Pozo, A.; Rekkas, D.M.; Volmer, D.; Hirvonen, J.T.; Božicˇ, B.; Skowron, A.; Mircioiu, C.;
Sandulovici, R.; Marcincal, A.; et al. Hospital and Community Pharmacists’ Perceptions of Which
Competences Are Important for Their Practice. Pharmacy 2016, 4, 21. [CrossRef] [PubMed]
9. Atkinson, J.; De Paepe, K.; Pozo, A.S.; Rekkas, D.M.; Volmer, D.; Hirvonen, J.T.; Božicˇ, B.; Skowron, A.;
Mircioiu, C.; Marcincal, A.; et al. A Study on How Industrial Pharmacists Rank Competences for Pharmacy
Practice: A Case for Industrial Pharmacy Specialization. Pharmacy 2016, 4, 13. [CrossRef] [PubMed]
10. The Spanish Hospital Pharmacy Aassociation. Available online: https://www.sefh.es/ (accessed on 30
January 2020).
11. The Portuguese Hospital Pharmacy Association. Available online: https://www.apfh.pt/ (accessed on 30
January 2020).
12. The Spanish National Law on Hospital Pharmacy. Available online: http://www.mscbs.gob.es/profesionales/
formacion/docs/realDecreto183_2008.pdf (accessed on 30 January 2020).
13. The Portuguese National Law on Hospital Pharmacy. Available online: http://www.infarmed.pt/web/
infarmed/legislacao/legislacao-farmaceutica-compilada/titulo-ii-enquadramento-geral-da-actividade-
farmaceutica/capitulo-v-farmacia-hospitalar (accessed on 30 January 2020).
14. The Directive 2013/55/EU of the European Parliament and of the Council of 20 November 2013.
Available online: https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=celex%3A32013L0055 (accessed
on 30 January 2020).
15. The Spanish Industrial Pharmacy Specialist Master. Available online: http://www.mscbs.gob.es/profesionales/
formacion/docs/Farmacia_Industrial_y_Galenica.pdf (accessed on 30 January 2020).
Pharmacy 2020, 8, 29 8 of 8
16. The Portuguese Industrial Pharmacy Specialist Masters: Mestrado Engenharia Farmacêutica ULisboa.
Available online: https://www.ff.ulisboa.pt/ensino/ensino-cursos/cursos-mestrados/engenharia-farmaceutica/
mestrado-em-engenharia-farmaceutica/ (accessed on 30 January 2020).
17. The Portuguese Industrial Pharmacy Specialist Masters: Mestrado Química Farmacêutica Industrial
UCoimbra. Available online: https://apps.uc.pt/courses/PT/course/1353 (accessed on 30 January 2020).
18. The Portuguese Industrial Pharmacy Specialist Masters: Mestrado Tecnologia Farmacêutica UPorto. Available
online: https://sigarra.up.pt/ffup/en/cur_geral.cur_view?pv_curso_id=1091 (accessed on 30 January 2020).
19. The Spanish Industrial Pharmacists Association. Available online: http://www.farmaindustria.es/web/
(accessed on 30 January 2020).
20. The Portuguese Industrial Pharmacists Association. Available online: https://www.apifarma.pt/Paginas/
Home.aspx (accessed on 30 January 2020).
21. The Courses for Hospital Pharmacy of the Spanish Hospital Pharmacy Association. Available online:
https://www.sefh.es/formacion.php (accessed on 30 January 2020).
22. The Courses for Hospital Pharmacy of the Portuguese Hospital Pharmacy Association. Available
online: https://www.ordemfarmaceuticos.pt/pt/a-ordem-dos-farmaceuticos/orgaos-sociais/colegios-de-
especialidade/farmacia-hospitalar/especialidade-de-farmacia-hospitalar (accessed on 30 January 2020).
23. Atkinson, J.; De Paepe, K.; Pozo, A.S.; Rekkas, D.M.; Volmer, D.; Hirvonen, J.T.; Božicˇ, B.; Skowron, A.;
Mircioiu, C.; Marcincal, A.; et al. Does the Subject Content of the Pharmacy Degree Course Influence the
Community Pharmacist’s Views on Competencies for Practice? Pharmacy 2015, 3, 137–153. [CrossRef]
[PubMed]
24. European Association of Faculties of Pharmacy—EAFP, Msida, Malta. Available online: http://eafponline.eu/
(accessed on 30 January 2020).
25. Conferencia Iberoamericana de Facultades de Farmacia—COIFFA, Mexico City, Mexico. Available online:
http://www.coiffa.org.mx/ (accessed on 30 January 2020).
26. Creative Commons. Available online: https://creativecommons.org/licenses/ (accessed on 30 January 2020).
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
